Valuation : Cutia Therapeutics

Market Cap 527M 616M 78.55M 67.53M 63.53M 57.98M 108M 7.45B 109M 753M 291M 3.81B 295M 289M 12.11B P/E 2026 *
-3.17x
P/E 2027 * 11.1x
Enterprise Value 596M 696M 88.78M 76.33M 71.81M 65.54M 122M 8.42B 123M 851M 329M 4.3B 333M 326M 13.69B EV / Sales 2026 *
0.92x
EV / Sales 2027 * 0.45x
Free-Float
32.66%
Yield 2026 *
-
Yield 2027 * -
1 day-2.65%
1 week-8.33%
Current month-13.61%
1 month-28.88%
3 months-49.54%
6 months-64.97%
Current year-63.66%
1 week 1.6
Extreme 1.6
1.77
1 month 1.6
Extreme 1.6
2.5
Current year 1.6
Extreme 1.6
5.51
1 year 1.6
Extreme 1.6
11.2
3 years 1.6
Extreme 1.6
25
5 years 1.6
Extreme 1.6
32.6
10 years 1.6
Extreme 1.6
32.6
Manager TitleAgeSince
Chief Executive Officer 48 2019-08-31
Director of Finance/CFO 36 2021-05-09
Chief Tech/Sci/R&D Officer 42 2020-01-09
Director TitleAgeSince
Director/Board Member 48 2020-05-11
Chairman 63 2019-08-22
Director/Board Member 36 2022-11-14
Date Insider Type Main position Quantity % Market Cap. Importance
10/15/24 Other

Founder

15,000 0.0049%
10/3/24 Other

Chief Financial Officer

20,000 0.0066%
10/2/24 Other

Chief Financial Officer

30,000 0.0098%
Change 5-day change 1-year change 3-year change Capi.($)
-2.65%-8.33%-84.92%-92.31% 78.79M
-2.21%-3.11%+52.16%+91.64% 1,024B
-2.22%-0.76%+51.08%+67.61% 663B
-2.99%-4.31%+18.59%+66.94% 453B
-0.88%+0.86%+29.77%+36.54% 349B
-10.89%-14.63%+9.27%+26.87% 295B
-1.38%-0.72%-0.79%+9.50% 253B
-10.08%-10.26%+40.32%+51.55% 236B
-2.32%-0.65%-15.84%-56.91% 206B
-2.88%-2.19%+26.54%+92.95% 187B
Average -3.51%-1.09%+12.62%+29.44% 366.74B
Weighted average by Cap. -2.42%-1.04%+32.69%+57.27%

Financials

2026 *2027 *
Net sales 646M 755M 96.23M 82.74M 77.84M 71.04M 133M 9.12B 133M 922M 357M 4.66B 361M 353M 14.84B 1.18B 1.38B 176M 151M 142M 130M 242M 16.66B 243M 1.68B 652M 8.52B 660M 646M 27.11B
Net income -146M -170M -21.71M -18.67M -17.56M -16.03M -29.91M -2.06B -30.07M -208M -80.51M -1.05B -81.53M -79.75M -3.35B 44.25M 51.7M 6.59M 5.67M 5.33M 4.87M 9.08M 625M 9.13M 63.18M 24.45M 319M 24.76M 24.22M 1.02B
Net Debt 68.7M 80.26M 10.24M 8.8M 8.28M 7.56M 14.1M 970M 14.17M 98.1M 37.95M 496M 38.44M 37.6M 1.58B -
Logo Cutia Therapeutics
Cutia Therapeutics is an investment holding company principally engaged in the dermatology biopharmaceutical business. The Company is dedicated to developing solutions in the dermatology treatment and care market, including scalp diseases and care, skin diseases and care, topical anesthesia and localized adipose accumulation management. The Company is primarily engaged in the distribution of scalp diseases and care products, as well as certain skin care products. The Company's principal pipeline products include topical finasteride spray CU-40102, topical 4% minocycline foam CU-10201, topical novel small molecule agent CU-10101, localized topical lidocaine and tetracaine cream CU-30101 and recombinant mutant collagenase CU-20401.
Employees
268
Date Price Change Volume
26-09-08 HK$1.650 -2.65% 8,000
26-09-08 HK$1.695 -0.29% 8,800
26-09-07 HK$1.700 -2.58% 255,000
26-09-04 HK$1.745 -0.29% 4,800
26-09-03 HK$1.750 -2.78% 28,400
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.451CNY
Average target price
9.801CNY
Spread / Average Target
+575.56%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2487 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!